Ocuphire Pharma Investor Presentation Deck

NYXOLⓇ EYE DROPS THREE INDICATIONS NEW PARTNERSHIP WITH VIATRIS TTT7 STZ VIATRIS™ RM P DLD Reversal of Mydriasis (RM) Presbyopia 1 Nyxol as a Single Drop 2 Pop SE HA 0.4% Nyxol with LDP Adjunctive Therapy L Dim Light or Night Vision Disturbances (DLD) 33

View entire presentation